Question 1

Am I eligible for this trial based on my current health and exercise habits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity clinical trial (NCT07091500). Contact the study team or your healthcare provider for specific answers.

Question 2

How does semaglutide compare to other weight loss options I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity clinical trial (NCT07091500). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of semaglutide and the exercise program?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity clinical trial (NCT07091500). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity clinical trial (NCT07091500). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I stop taking the medication after the trial ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity clinical trial (NCT07091500). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or travel requirements I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity clinical trial (NCT07091500). Contact the study team or your healthcare provider for specific answers.

What this study is about